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The timing of puberty is highly variable1. We carried out a genome-wide association study for age
at menarche in 4,714 women and report an association in LIN28B on chromosome 6 (rs314276,
minor allele frequency (MAF) = 0.33, P = 1.5 × 10−8). In independent replication studies in
16,373 women, each major allele was associated with 0.12 years earlier menarche (95% CI =
0.08–0.16; P = 2.8 × 10−10; combined P = 3.6 × 10−16). This allele was also associated with earlier
breast development in girls (P = 0.001; N = 4,271); earlier voice breaking (P = 0.006, N = 1,026)
and more advanced pubic hair development in boys (P = 0.01; N = 4,588); a faster tempo of height
growth in girls (P = 0.00008; N = 4,271) and boys (P = 0.03; N = 4,588); and shorter adult height
in women (P = 3.6 × 10−7; N = 17,274) and men (P = 0.006; N = 9,840) in keeping with earlier
growth cessation. These studies identify variation in LIN28B, a potent and specific regulator of
microRNA processing2, as the first genetic determinant regulating the timing of human pubertal
growth and development.
Puberty, the transition from childhood to adult body size and sexual maturity, is a complex
multistaged process involving growth acceleration, weight gain and the appearance of
secondary sexual physical features over a 2- to 3-year period1. Early onset and progression
of puberty is seen in some overweight and obese children. In addition to its psycho-social
and public health implications, early puberty is associated with increased long-term risk for
diseases including obesity, diabetes and cancer3. The stages of puberty and their transitions
are difficult to measure accurately1. Epidemiological studies often use age at menarche, the
onset of the first menstrual period in girls, to indicate the timing of puberty, as this distinct
event is often well recalled many years later1. Girls with earlier menarche are heavier and
taller than other girls during childhood; they remain heavier but are shorter as adults3,
reflecting their earlier cessation of growth. Twins studies estimate that 44–95% of the
variance in age at menarche may be heritable1. However, specific common genetic variants
that influence the timing of puberty have not yet been convincingly demonstrated4.
To identify common variants associated with the timing of puberty, we conducted a
genome-wide association (GWA) study for age at menarche in 4,714 women from two
general population studies and one obese case study using the same Affymetrix GeneChip
500K array (Supplementary Note online). Only one SNP, rs314276 in intron 2 of LIN28B
on chromosome 6 (MAF 0.33), reached genome-wide statistical significance (P = 1.5 ×
10−8, Supplementary Fig. 1 online). In these GWA studies overall each major C allele at
rs314276 was associated with a mean 0.22 years (95% CI = 0.14–0.29) earlier age at
menarche.
SNP rs314276 lies in a region of high linkage disequilibrium (LD); although no other SNPs
in this region were directly genotyped in these arrays, imputation to HapMap build 35
revealed a further 11 SNPs in LIN28B that were associated with age at menarche at P < 0.5
× 10−7 (Fig. 1). The minor allele at a neighboring SNP, rs314277, 337 bp downstream of
rs314276, was recently robustly associated with taller adult height5. In our GWA studies
imputed rs314277 genotypes showed only nominal association with age at menarche (P =
0.005). However, as there was low LD between rs314276 and rs314277 (r2 = 0.23; D = 1.0)
we took both SNPs forward to initial replication.
Study of mothers from the ALSPAC cohort (N = 6,456) confirmed the association between
rs314276 and age at menarche (P = 6.6 × 10−5). Each common C allele was associated with
a mean 0.10 years (95% CI = 0.07–0.13) earlier menarche, the association seemed to be
linear (Supplementary Fig. 2 online) and rs314276 explained 0.2% of the variance in age at
menarche. In contrast, the adjacent SNP rs314277 was not associated with age at menarche
(P = 0.08). In multiple regression analysis including both SNPs, rs314276 (P = 0.0006), but
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not rs314277 (P = 0.6), was associated with age at menarche. The association between
rs314276 and age at menarche was further confirmed in women from the EPIC-Norfolk
cohort (P = 8.7 × 10−6, N = 8,411), the MRC National Study of Health and Development
(NSHD) (P = 0.02; N = 948) and the British 1958 Birth Cohort (B58C) (P = 0.007; N = 558;
Fig. 2 and Supplementary Fig. 2). In a meta-analysis of all replication studies (total N =
16,373 women), each rs314276 C allele was associated with 0.12 years earlier menarche
(95% CI = 0.08–0.16; P = 2.8 × 10−10; Fig. 2). Notably, the pooled regression coefficient in
the replication studies was only around half of that in the GWA studies (heterogeneity
between initial and replication studies: P = 0.02; Fig. 2), likely reflecting the ‘winner's
curse’ phenomenon.
Although menarche represents the completion of female sexual maturation and attainment of
reproductive capacity, the onset of puberty in girls typically occurs 2-3 years earlier and is
manifested by the onset of breast growth and acceleration in height and weight gain. To
explore its association with the timing of pubertal onset, we genotyped rs314276 in various
childhood studies (see Table 1 for summary).
In ALSPAC girls (N = 4,271), the common C allele at rs314276 was associated with earlier
onset of breast development (Fig. 3, log-rank test: P = 0.001). At age 10.75 years each C
allele was associated with a 20% increased likelihood of breast development (odds ratio
(OR) = 1.20, 95% CI = 1.06–1.35; P = 0.003). In the cross-sectional European Youth Heart
Study (EYHS), across all age groups from 9 to 16 years the common C allele at rs314276
was associated with more advanced breast stage in girls (OR = 1.26, 95% CI = 1.05–1.52; P
= 0.006; N = 1,044) (Table 1 and Supplementary Table 1 online). In ALSPAC girls, the
rs314276 C allele was associated with a faster tempo of growth in height between ages 7 and
11 years (P = 0.00008), and relative acceleration in weight (P = 0.0003) and body mass
index (BMI) (P = 0.03) (Fig. 4).
In boys, the onset and progression of puberty are manifested by a gradual enlargement of the
external genitalia and the spread of pubic hair. By convention these characteristics are
categorized into five stages of sexual maturation; however, in epidemiological studies these
stages are difficult to assign accurately. Equivalent to menarche in girls, voice breaking in
boys represents a distinct event, which typically occurs abruptly in late puberty6. In NSHD
men (N = 1,027) at age 15 years the common C allele at rs314276 was associated with more
advanced pubic hair stage (P = 0.05), more advanced voice breaking status (P = 0.006) and
also more advanced tempo of height growth (P = 0.03), but no apparent difference in genital
size (Table 1 and Supplementary Table 2 online). In ALSPAC boys (total N = 4,588), the C
allele at rs314276 was associated with more advanced pubic hair at age 13 years (OR for a
one-stage advance in pubic hair stage per C allele = 1.19, 95% CI = 1.04–1.35; P = 0.01),
and with a faster tempo of growth in height between ages 7 and 11 years (P = 0.03;
Supplementary Fig. 3 online). In the smaller sample of EYHS boys (total N = 910, no
association was found with genital or pubic hair stages at ages 9–11 years or 14–16 years
(Supplementary Table 1).
In contrast to their relatively taller stature during childhood, men and women with early
puberty are shorter as adults, owing to their earlier cessation of growth, but they remain
heavier and more overweight3. Consistent with its associations with earlier puberty, the
rs314276 C allele was also associated with shorter adult height in ALSPAC mothers (mean
± s.e.m. difference: −0.37 ± 0.12 cm per C allele, P = 0.002), EPIC-Norfolk women (−0.36
± 0.10 cm, P = 0.0002) and EPIC-Norfolk men (−0.30 ± 0.11 cm, P = 0.006). In multiple
regression among ALSPAC mothers including both rs314276 and rs314277, rs314276 (P =
0.003) but not rs314277 (P = 0.3) was associated with adult height. In contrast to the
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findings with adult height, rs314276 showed no association with adult weight, BMI, waist
circumference or percentage body fat (all P > 0.10, see Supplementary Table 3 online)
Several candidate genes, encoding regulators of sex steroid secretion and action, have been
proposed to regulate the timing of puberty; however, no common variants have yet been
established4. In our GWA studies, SNPs in FGFR1, GOLT1A, KISS1, LEPR and SHBG
showed modest associations with age at menarche (0.01 < P < 0.05; Supplementary Table 4
online). Our study therefore reinforces the merits of the genome-wide compared to the
candidate gene approach, although much larger studies will be needed to identify the likely
large number of SNPs associated with timing of puberty.
A recent GWA study for adult height identified rs314277 as one of ten loci with robust
associations (P = 5.9 × 10−9 in 15,821 individuals), whereas rs314276 showed far weaker
association (P ~ 1 × 10−4); however, rs314276 was not directly genotyped in many of those
samples5. In our study, where both SNPs were directly genotyped, the effects of rs314277
on height were explained by rs314276. rs314276 lies in a large LD block of around 200 kb
that covers the 5′ region and first three exons of LIN28B. Imputation revealed a further 11
SNPs that were in complete LD with rs314276 and that also reached genome-wide
association with age at menarche. Fine mapping studies in similar populations of European
ancestry are therefore unlikely to be able to distinguish the causal variant(s) from other
linked variants. LIN28B has two isoforms7 distinguished by the presence or truncation of a
highly conserved cold-shock domain (CSD), which is crucial for protein function2. Different
LIN28B isoforms could therefore contribute to the heritability of the timing of growth and
development.
LIN28B shows high sequence, structural and functional homology with LIN28 on
chromosome 1 (ref. 7); however, we found no association with 12 directly genotyped or
imputed SNPs in LIN28 (all P > 0.2; see Supplementary Table 4). Both LIN28B and LIN28
show similar sequence homology to the heterochronic gene lin-28 in Caenorhabditis
elegans7. Deleterious mutations in lin-28 produce an abnormal rapid tempo of development
through larval stages to adult cuticle formation8. Conversely, enhancement of lin-28
expression by deletion of regulatory elements delays larval stage progression9. Both
LIN28B and LIN28 encode potent and specific regulators of pre-processing of the let7
family of microRNAs2 and regulate cell pluripotency10 and cancer growth7.
In conclusion, we have identified SNP rs314276, or another related variant within LIN28B,
as the first genetic marker associated with the timing of pubertal growth and development
and in both girls and boys. Our findings suggest the conservation of a fundamental cell
regulatory system that controls the tempo of somatic development and also suggest a




EPIC-Norfolk Obesity Case-Cohort—The control cohort comprised 2,566 individuals
(1,364 women) randomly selected from the EPIC-Norfolk study of 25,663 men and women
of European descent. The case cohort comprised 1,685 obese individuals (718 women),
defined as BMI index >30 kg/m2, randomly selected from the obese individuals within
EPIC-Norfolk. Participants were aged 39–79 years and were recruited in Norfolk, UK
between 1993 and 1997 (ref. 11). Following exclusions due to quality control criteria and
missing data, on 625 obese and 1,215 control women were available for genome-wide
analysis.
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Cohorte LAUSannoise (CoLaus)—CoLaus is a cross-sectional study of a random
sample of 6,188 European adults (including 2,976 women), aged 35–75 years, living in
Lausanne, Switzerland12. Following exclusions due to quality control criteria and missing
data, 2,874 women were included in the genome-wide analyses.
In all studies, age at menarche to the nearest completed whole year was ascertained at
baseline by questionnaire. Values ranging from 8 to 18 years were included as these were
deemed to be physiological. All participants gave written informed consent, and project
protocols were approved by the appropriate research ethics committees (Supplementary
Note).
Genome-wide SNP genotyping and quality control
All GWA studies were genotyped using the Affymetrix GeneChip 500K array set, and
genotypes were called using the BRLMM algorithm. Each study applied genotyping quality
control criteria and conducted tests for population stratification: 352,700 SNPs passed
quality control in EPIC-Norfolk and 390,631 in the CoLaus cohort. In CoLaus correction for
population substructure was done by principal components. The genomic control inflation
factors (lGC) for each GWA study were <1 for EPIC-Norfolk control cohort and obese cases
and 1.016 in CoLaus, indicating that the extent of residual population substructure is
modest, and no further genomic control corrections were applied.
Genome-wide analyses and meta-analyses
Age at menarche showed a normal distribution. In each GWA study, linear regression was
carried out (assuming an additive model) to test the association between each SNP and age
at menarche using PLINK (CoLauS) or SAS/Genetics 9.1 (EPIC-Norfolk). Subsequently,
summary statistics of the SNP-menarche age associations of each GWA study were
combined in meta-analyses using the inverse variance–weighted method with a fixed-effects
model using SAS 9.1. The overall results of the meta-analysis were visualized using
HAPLOVIEW.
Imputation of genotypes
To increase genomic coverage, polymorphic HapMap CEU SNPs were imputed using
IMPUTE. Associations with age at menarche were subsequently tested with these imputed
SNPS using linear regression under additive genetic assumptions.
Replication samples
Initial replication of the top hit rs314276 and adjacent rs314277 was done in mothers from
the Avon Longitudinal Study of Parents and Children (ALSPAC). This population-based
study recruited pregnant women with expected delivery dates between April 1991 and
December 1992 from Bristol, UK13. Genotypes for rs314276 and rs314277 and recalled
menarche data were available for 6,456 mothers. Replication samples were also available
from a further 10,824 women in the EPIC-Norfolk Study, excluding women who had been
analyzed in the GWA study. rs314276 was directly genotyped in 10,453 women, of whom
8,411 had valid data on age at menarche. SNP rs314276 was genotyped in a further 948
women with a valid age at menarche from the MRC National Survey of Health and
Development (NSHD), a prospective birth cohort study comprising a stratified sample of all
births in England, Scotland and Wales in one week in March 1947 (ref. 14). A further 558
women from the 1958 British Birth Cohort (B58C), a prospective birth cohort originally
consisting of all births in England, Wales and Scotland during one week in 1958, had
rs314276 genotypes and age at menarche data available.
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Replication genotyping and quality control
Genotyping of rs314276 and rs314277 was conducted using TaqMan (Applied Biosystems)
(EPIC and NSHD) or by KBiosciences (ALSPAC). Genotype data from B58C was obtained
using an Affymetrix GeneChip Human Mapping 500K Array. Genotype frequencies were in
Hardy-Weinberg equilibrium (all P > 0.2), and call rates were all >90%.
Statistical analyses in replication studies
Associations between SNPs and age at menarche (women only), height, weight, BMI, waist
circumference and percentage body fat were conducted in men and women separately using
linear regression assuming an additive genetic model and adjusting for age. In ALSPAC
mothers, multiple regression models were performed including both rs314276 and rs314277
to identify the independent effects of each SNP on age at menarche and height. Summary
statistics were meta-analyzed with the initial GWA study sets using the inverse variance–
weighted method. Analyses were performed using Stata/s.e.m. 9.2 for Windows (StataCorp).
Childhood studies
We analyzed 8,859 ALSPAC children (4,588 boys and 4,271 girls) to examine the
association between rs312726 genotype and timing of adolescent growth (between ages 7 to
11 years), pubic hair stage in boys and breast development in girls. Data on pubertal
development (voice breaking status and pubic hair stage) at age 15 years were available for
NSHD men (N = 1,026). We analyzed 1,964 individuals from the Danish and Estonian
cohorts of the cross-sectional European Youth Heart Study (EYHS) to determine the
association between rs312726 and pubertal stage.
Childhood studies genotyping and quality control
rs314276 was genotyped using TaqMan SNP genotyping assay (Applied Biosystems)
(EYHS) or by KBiosciences (ALSPAC). Genotype frequencies were in Hardy-Weinberg
equilibirum (all P > 0.1), and call rates were all >96%.
Statistical analyses in childhood studies
Height, weight and BMI measurements in each individual were converted to s.d. scores
(SDS) adjusted for sex and age. Growth tempo, a measure of child's current height relative
to height potential, was calculated as the child's height SDS minus their mean parental
height SDS15. Associations between rs314276 and changes in growth tempo, weight and
BMI SDS between ages 7 to 11 years were calculated using time series analyses (repeated
measures ANOVA). Association between rs314276 and the onset of pubertal breast
development in girls was calculated using a log-rank test. Cross-sectional associations
between rs314276 and pubertal stage in girls and boys were done by ordinal logistic
regression. All analyses assumed an additive genetic model, and were done using SPSS v.14
for Windows.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Regional plot of the locus around LIN28B associated with age at menarche. SNPs are
plotted by position on chromosome 6 against GWAS association with age at menarche
(−log10 P value). SNP rs314276 is shown in blue, labeled with its stage 1 P value. Estimated
recombination rates (from HapMap) are plotted in cyan to reflect the local LD structure. The
directly genotyped or imputed SNPs surrounding rs314276 are color-coded to reflect their
LD with rs314276 as in the inset (taken from pairwise r2 values from the HapMap CEU
database). Genes and their directions of transcription are noted at the bottom of the plot.
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A forest plot showing the meta-analysis of the effect of each C allele at rs314276 in LIN28B
on earlier age at menarche in the GWA populations, the replication cohorts and in all
groups.
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Kaplan-Maier plot of survival in pre-pubertal status (Tanner breast stage 1) by age and
LIN28B rs314276 genotype in ALSPAC girls (N = 3,233). P = 0.001, log-rank test for
genotype difference.
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Adolescent growth in ALSPAC girls by LIN28B rs314276 genotype. (a–c) Mean (± s.e.)
standard deviation scores (SDS) for tempo of growth (child's height SDS minus mean
parental height SDS) (a), weight (b) and BMI (c) are plotted against age from 7 to 11 years
by genotype. P values (0.00008, 0.0003 and 0.03 for height, weight and BMI, respectively)
are from time-series analyses (repeated measures ANOVA) for the change in SDS over time
by genotype (additive genetic models).
Ong et al. Page 11

















Ong et al. Page 12
Table 1
Summary of the pubertal and growth phenotype associations with LIN28B rs314276 genotype
Variable Estimated effect per C allele
mean/odds ratio (95% CI)
P value Study population
Girls/Women
 Earlier menarche −0.12 years (−0.08 to −0.16) 2.8 × 10−10 ALSPAC mothers,
EPIC-Norfolk, NSHD, B58C
 More likely breast development at 10 yearsa OR = 1.20 (1.06 to 1.35) 0.003 ALSPAC girls
 More advanced breast stage at ages 9 to 16 yearsb OR = 1.26 (1.05 to 1.52) 0.006 EYHS
 Faster height tempo at age 10 yearsc 0.074 SDS (0.042 to 0.106) 0.02 ALSPAC girls
 Shorter adult height −0.37 cm (−0.51 to −0.22) 3.6 × 10−7 ALSPAC mothers,
EPIC-Norfolk
Boys/Men
 More advanced voice breaking status at age 15 yearsd OR = 1.26 (1.07 to 1.50) 0.006 NSHD
 More advanced pubic hair stage at age 13 yearse OR = 1.19 (1.04 to 1.35) 0.01 ALSPAC boys
 More advanced pubic hair stage at age 15 yearsf OR = 1.18 (0.99 to 1.40) 0.05 NSHD
 Faster height tempo at age 10 yearsc 0.085 SDS (0.054 to 0.116) 0.005 ALSPAC boys
 Shorter adult height −0.30 cm (−0.41 to −0.19) 0.006 EPIC-Norfolk
a
Breast development was defined as Tanner stage 2 or greater.
b
Breast stage was defined by the five-point Tanner scale.
c
Height tempo was calculated as height s.d. score minus parental height s.d. score.
dVoice breaking status was categorized using the following scale: 1, no; 2, starting to break; 3, completely broken.
e
Pubic hair stage was defined by the five-point Tanner scale.
f
Pubic hair stage was categorized using the following scale: 1, no; 2, yes, sparse; 3, yes, profuse.
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